Safety of High-dose Tirofiban During Coronary Angioplasty

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This single-centre study is intended to retrospectively check the safety of high-dose bolus of tirofiban in patients who underwent percutaneous angioplasty.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: S. Anna Hospital
• Treatments: Clopidogrel; Tirofiban

Criteria

Inclusion Criteria:

• Patients undergoing percutaneous coronary angioplasty

Exclusion Criteria:

• Known allergy to tirofiban